A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition-Reference-Cited by-同舟云学术

A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition

Published:2013-03 Issue:3 Volume:12 Page:316-328
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Goff Daniel J.,Recart Angela Court,Sadarangani Anil,Chun Hye-Jung,Barrett Christian L.,Krajewska Maryla,Leu Heather,Low-Marchelli Janine,Ma Wenxue,Shih Alice Y.,Wei Jun,Zhai Dayong,Geron Ifat,Pu Minya,Bao Lei,Chuang Ryan,Balaian Larisa,Gotlib Jason,Minden Mark,Martinelli Giovanni,Rusert Jessica,Dao Kim-Hien,Shazand Kamran,Wentworth Peggy,Smith Kristen M.,Jamieson Christina A.M.,Morris Sheldon R.,Messer Karen,Goldstein Lawrence S.B.,Hudson Thomas J.,Marra Marco,Frazer Kelly A.,Pellecchia Maurizio,Reed John C.,Jamieson Catriona H.M.

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference71 articles.

1. Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy;Abe;Int. J. Hematol.,2008

2. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation;Abrahamsson;Proc. Natl. Acad. Sci. USA,2009

3. Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides;Aichberger;Blood,2005

4. Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications;Akgul;Cell. Mol. Life Sci.,2004

5. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL;Amarante-Mendes;Oncogene,1998

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code;FEBS Letters;2024-09-09

2. A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells;2024-09-06

3. Is There a Role for Combination Therapy, And If So, What Combinations?;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. CAR-T cell combination therapies in hematologic malignancies;Experimental Hematology & Oncology;2024-07-18

5. BCL-2 inhibition in haematological malignancies: Clinical application and complications;Blood Reviews;2024-05